Not all clients with CLL need therapy. Irrespective of all latest improvements, the iwCLL even now recommends watchful observation for clients with asymptomatic illness.86 This suggestion is based on not less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Partisipasi aktif dari https://teresab086ygz0.nytechwiki.com/user